Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections

Clinical Microbiology Reviews

Volumn 11, Issue 3, 1998, Pages 450-479

  Paton, James C ^a   Paton, Adrienne W ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; ANTIBIOTIC AGENT; ANTITOXIN; CIPROFLOXACIN; COTRIMOXAZOLE; ESCHERICHIA COLI ENTEROTOXIN; GLYCOLIPID; HEMOLYSIN; MONOCLONAL ANTIBODY; RECEPTOR; SERINE PROTEINASE; SHIGA TOXIN; SYNSORB PK; UNCLASSIFIED DRUG; VACCINE;

BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELL SEPARATION; CLINICAL FEATURE; CYTOTOXICITY TEST; DNA HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI O157; FOOD POISONING; GASTROINTESTINAL DISEASE; GENE STRUCTURE; GENETIC ANALYSIS; GRAM NEGATIVE INFECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTESTINE EPITHELIUM CELL; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OLIGONUCLEOTIDE PROBE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; SEROTYPE; TISSUE CULTURE;

EID: 0031848112     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.3.450     Document Type: Review

References (385)

1. Abaas, S., A. Franklin, I. Kuhn, F. Orskov, and I. Orskov. 1989. Cytotoxin activity on Vero cells among Escherichia coli strains associated with diarrhea in cats. Am. J. Vet. Res. 50:1294-1296.
2. Acheson, D., M. Jacewicz, L. Lincicome, D. Bielinski, D. Binion, G. West, C. Fiocchi, and G. Keusch. 1997. Shiga toxin action on human intestinal microvascular endothelial cells (HIMEC), abstr. V144/V, p. 87. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y..
3. Acheson, D. W., M. M. Levine, J. B. Kaper, and G. T. Keusch. 1996. Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio choleras CVD 103-HgR. Infect. Immun. 64:355-357.
4. Acheson, D. W., R Moore, S. De-Breucker, L. Lincicome, M. Jacewicz, E. Skutelsky, and G. T. Keusch. 1996. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect. Immun. 64:3294-3300.
5. Acheson, D. W. K., S. De Breucker, A. Donohue-Rolfe, K. Kozak, A. Yi, and G. T. Keusch. 1994. Development of a clinically useful diagnostic enzyme immunoassay for enterohemorrhagic Escherichia coli infection, p. 109-112. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
6. Acheson, D. W. K., and A. Donohue-Rolfe. 1989. Cancer-associated hemolytic uremic syndrome. A possible role of mitomycin C in relation to Shiga-like toxins. J. Clin. Oncol. 7:1943.
7. 1 glycoprotein from hydatid cysts. J. Infect. Dis. 161:134-137.
8. Ackman, D., S. Marks, P. Mack, M. Caldwell, T. Root, and G. Birkhead. 1997. Swimming associated haemorrhagic colitis due to Escherichia coli O157:H7 infection: evidence of prolonged contamination of a fresh water lake. Epidemiol. Infect. 119:1-8.
9. Adak, G., H. Smith, G. Willshaw, T. Cheasty, P. Wall, and B. Rowe. 1997. A review of outbreaks of vero cytotoxin producing Escherichia coli O157 in England and Wales, 1992-1996, abstr. V75/I, p. 10. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y..
10. Ahmed, S., and J. Cowden. 1997. An outbreak of E. coli O157 in central Scotland, abstr. V191/I, p. 22. In 3rd International Symposium and Work-shop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y..
11. Armstrong, G. D., E. Fodor, and R. Vanmaele. 1991. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164:1160-1167.
12. Armstrong, G. D., and P. Rowe. 1997. Clinical trials of Synsorb-Pk in preventing HUS. Presented at the 3rd International Symposium and Work-shop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y..
13. Armstrong, G. D., P. C. Rowe, P. Goodyer, E. Orrbine, T. P. Klassen, G. Wells, A. MacKenzie, H. Lior, C. Blanchard, F. Auclair, B. Thompson, D. J. Rafter, and P. N. McLaine. 1995. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J. Infect. Dis. 171: 1042-1045.
14. 3), their natural receptor. J. Clin. Microbiol. 27:1145-1150.
15. Ashkenazi, S., and T. G. Cleary. 1990. A method for detecting Shiga toxin and Shiga-like toxin-I in pure and mixed culture. J. Med. Microbiol. 32: 255-261.
16. Azim, T., A. Ronan, W. A. Khan, M. A. Salam, M. J. Albert, and M. L. Bennish. 1997. Features of Shigella-associated hemolytic uremic syndrome (HUS) in children, abstr. V187/I, p. 22. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
17. Bain, C., R. Keller, and S. Knutton. 1997. Increased levels of intracellular calcium are not required for the formation of attaching and effacing lesions by enteropathogenic (EPEC) or enterohemorrhagic Escherichia coli (EHEC), abstr. V17/III, p. 46. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
18. Baker, D. R., R. A. Moxley, and D. H. Francis. 1997. Variation in virulence in the gnotobiotic pig model of O157:H7 Escherichia coli strains of bovine and human origin. Adv. Exp. Med. Biol. 412:53-58.
19. Ball, H. J., D. Finlay, A. Zafar, and T. Wilson. 1996. The detection of verocytotoxins in bacterial cultures from human diarrhoeal samples with monoclonal antibody-based ELISAs. J. Med. Microbiol. 44:273-276.
20. Barrett, T. J., J. H. Green, P. M. Griffin, A. T. Pavia, S. M. Ostroff, and I. K. Wachsmuth. 1991. Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr. Microbiol. 23:189-195.
21. Barrett, T. J., J. B. Kaper, A. E. Jerse, and I. K. Wachsmuth. 1992. Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. J. Infect. Dis. 165:979-980.
22. Bast, D. J., J. L. Brunton, M. A. Karmali, and S. E. Richardson. 1997. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits. Infect. Immun. 65:2019-2028.
23. Bast, D. J., H. Ling, L. Banerjee, C. Lingwood, R. Read, and J. Brunton. 1997. Mutational analysis of the Verotoxin-1 B-subunit: evidence for three distinct Gb3 binding domains, abstr. V120/III, p. 56. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
24. Basta, M., M. Karmali, and C. Lingwood. 1989. Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin. J. Clin. Microbiol. 27:1617-1622.
25. Bastin, D. A., and P. R. Reeves. 1995. Sequence analysis of the O antigen gene (rfb) cluster of Escherichia coli O111. Gene 164:17-23.
26. Bauer, M. E., and R. A. Welch. 1996. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 64:167-175.
27. Beebakhee, G., M. Louie, J. De Azavedo, and J. Brunton. 1992. Cloning and nucleotide sequence of the eae gene homologue from enterohemorrhagic Escherichia coli serotype O157:H7. FEMS Microbiol. Lett. 91:63-68.
28. Begum, D., and M. P. Jackson. 1995. Direct detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction. Mol. Cell. Probes 9:259-264.
29. Begum, D., N. A. Strockbine, E. G. Sowers, and M. P. Jackson. 1993. Evaluation of a technique for identification of Shiga-like toxin-producing Escherichia coli by using polymerase chain reaction and digoxigenin-labeled probes. J. Clin. Microbiol. 31:3153-3156.
30. Bell, B. P., P. M. Griffin, P. Lozano, D. L. Christie, J. M. Kobayashi, and P. I. Tarr. 1997. Predictors of hemolytic uremic syndrome during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100:127(E12).
31. Beutin, L., D. Geier, H. Steinruck, S. Zimmermann, and F. Scheutz. 1993. Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J. Clin. Microbiol. 31:2483-2488.
32. Beutin, L., D. Geier, S. Zimmermann, and H. Karch. 1995. Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J. Clin. Microbiol. 33:631-635.
33. Beutin, L., M. A. Montenegro, I. Orskov, F. Orskov, J. Prada, S. Zimmermann, and R. Stephan. 1989. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J. Clin. Microbiol. 27:2559-2564.
34. Beutin, L., S. Zimmermann, and K. Gleier. 1996. Pseudomonas aeruginosa can cause false-positive identification of verotoxin (Shiga-like toxin) production by a commercial enzyme immune assay system for the detection of Shiga-like toxins (SLTs). Infection 24:267-268.
35. Beutin, L., S. Zimmermann, and K. Gleier. 1996. Rapid detection and isolation of Shiga-like toxin (verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay. J. Clin. Microbiol. 34:2812-2814.
36. Bhakdi, S., M. Muhly, S. Korom, and G. Schmidt. 1990. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J. Clin. Invest. 85:1746-1753.
37. Bhimma, R., N. Rollins, H. M. Coovadia, and M. Adhakiri. 1997. Hemolytic uremic syndrome following a Shigella dysenteriae type 1 outbreak in South Africa, abstr. V208/I, p. 24. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
38. Bielaszewska, M., I. Clarke, M. A. Karmali, and M. Petric. 1997. Localization of intravenously administered verotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect. Immun. 65:2509-2516.
39. Bielaszewska, M., J. Janda, K. Blahova, J. Feber, V. Potuznik, and A. Souckova. 1996. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. Clin. Nephrol. 46:42-44.
40. - in the Czech Republic, abstr. V9/I, p. 1. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
41. Bilge, S. S., J. C. Vary, Jr., S. F. Dowell, and P. I. Tarr. 1996. Role of the Escherichia coli O157:H7 O side chain in adherence and analysis of an rfb locus. Infect. Immun. 64:4795-4801.
42. Bitzan, M., and H. Karch. 1992. Indirect hemagglutination assay for diagnosis of Escherichia coli 0157 infection in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 30:1174-1178.
43. Bitzan, M., E. Moebius, K. Ludwig, D. E. Muller-Wiefel, J. Heesemann, and H. Karch. 1991. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J. Pediatr. 119:380-385.
44. Bitzan, M., S. Richardson, C. Huang, B. Boyd, M. Petric, and M. A. Karmali. 1994. Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Infect. Immun. 62:3337-3347.
45. Bosworth, B. T., J. E. Samuel, H. W. Moon, A. D. O'Brien, V. M. Gordon, and S. C. Whipp. 1996. Vaccination with genetically modified Shiga-like toxin He prevents edema disease in swine. Infect. Immun. 64:55-60.
46. Boyd, B., H. C. Hansen, G. Magnusson, and C. A. Lingwood. 1997. A divalent galabiosyl analogue inhibits VT1/Gb3 binding in vitro and protects cells against VT1 and VT2, abstr. V94/III, p. 53. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
47. Boyd, B., and C. A. Lingwood. 1989. Verotoxin receptor glycolipid in human renal tissue. Nephron. 51:207-210.
48. Boyd, B., S. Richardson, and J. Gariepy. 1991. Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin. Infect. Immun. 59:750-757.
49. Boyd, B., G. Tyrrell, M. Maloney, C. Gyles, J. Brunton, and C. Lingwood. 1993. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in averotoxin 1-like disease in pigs. J. Exp. Med. 177:1745-1753.
50. Brian, M. J., M. Frosolono, B. E. Murray, A. Miranda, E. L. Lopez, H. F. Gomez, and T. G. Cleary. 1992. Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome. J. Clin. Microbiol. 30:1801-1806.
51. Brown, J. E., O. Sethabutr, M. P. Jackson, S. Lolekha, and P. Echeverria. 1989. Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant Shiga-like toxin II with synthetic oligonucleotide probes. Infect. Immun. 57:2811-2814.
52. Brunder, W., H. Schmidt, and H. Karch. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol. 24:767-778.
53. Butterton, J. R., E. T. Ryan, D. W. K. Acheson, and S. B. Calderwood. 1997. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect. Immun. 65:2127-2135.
54. Calderwood, S. B., D. W. K. Acheson, G. T. Keusch, T. J. Barrett, P. M. Griffin, N. A. Strockbine, B. Swaminathan, J. B. Kaper, M. M. Levine, B. S. Kaplan, H. Karch, A. D. O'Brien, T. G. Obrig, Y. Takeda, P. I. Tarr, and I. K. Wachsmuth. 1996. Proposed new nomenclature for SLT (VT) family. ASM News 62:118-119.
55. Calderwood, S. B., F. Auclair, A. Donohue-Rolfe, G. T. Keusch, and J. J. Mekalanos. 1987. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc. Natl. Acad. Sci. USA 84:4364-4368.
56. Calderwood, S. B., and J. J. Mekalanos. 1987. Iron regulation of Shiga-like toxin production in Escherichia coli is regulated by the fur locus. J. Bacteriol. 169:4759-4764.
57. Caprioli, A., I. Luzzi, F. Rosmini, C. Resti, A. Edefonti, F. Perfumo, C. Farina, A. Goglio, A. Gianviti, and G. Rizzoni. 1994. Community-wide outbreak of hemoiytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J. Infect. Dis. 169:208-211.
58. Caprioli, A., A. Nigrelli, R. Gatti, M. Zavanella, A. M. Blando, F. Minelli, and G. Donelli. 1993. Characterisation of verocytotoxin-producing Escherichia coli isolated from pigs and cattle in northern Italy. Vet. Rec. 133: 323-324.
59. Carter, A. O., A. A. Borczyk, J. A. K. Carlson, B. Harvey, J. C. Hockin, M. A. Karmali, C. Krishnan, D. A. Korn, and H. Lior. 1987. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N. Engl. J. Med. 317:1496-1500.
60. Cebula, T. A., W. L. Payne, and P. Feng. 1995. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J. Clin. Microbiol. 33:248-250. (Erratum, 33:1048.)
61. Centers for Disease Control. 1982. Isolation of E. coli O157:H7 from sporadic cases of hemorrhagic colitis-United States. Morbid. Mortal. Weekly Rep. 31:580.
62. Centers for Disease Control and Prevention. 1995. Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami-Washington and California, 1994. Morbid. Mortal. Weekly Rep. 44:157-160.
63. Centers for Disease Control and Prevention. 1995. Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21-Helena, Montana, 1994. Morbid. Mortal. Weekly Rep. 44:501-503.
64. Chapman, P. A., and C. A. Siddons. 1996. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from cases of bloody diarrhoea, non-bloody diarrhoea and asymptomatic contacts. J. Med. Microbiol. 44:267-271.
65. Chapman, P. A., C. A. Siddons, P. M. Zadik, and L. Jewes. 1991. An improved selective medium for the isolation of Escherichia coli O157. J. Med. Microbiol. 35:107-110.
66. Chapman, P. A., D. J. Wright, and C. A. Siddons. 1994. A comparison of immunomagnetic separation and direct culture for the isolation of verocy-totoxin-producing Escherichia coli O157 from bovine faeces. J. Med. Microbiol. 40:424-427.
67. Chart, H., D. Law, B. Rowe, and D. W. Acheson. 1993. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2. J. Clin. Pathol. 46:1053-1054.
68. Chart, H., H. R. Smith, S. M. Scotland, B. Rowe, D. V. Milford, and C. M. Taylor. 1991. Serological identification of Escherichia coli infection in haemolytic uraemic syndrome. Lancet 337:138-140.
69. Cimolai, N., S. Basalyga, D. G. Mah, B. J. Morrison, and J. E. Carter. 1994. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. Clin. Nephrol. 42:85-89.
70. Cimolai, N., J. E. Carter, B. J. Morrison, and J. D. Anderson. 1990. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J. Pediatr. 116:1496-1500.
71. Clark, C., D. Bast, A. M. Sharp, P. M. St.-Hilaire, R. Agha, P. E. Stein, E. J. Toone, R. J. Read, and J. L. Brunton. 1996. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1. Mol. Microbiol. 19:891-899.
72. Clarke, R. C., J. B. Wilson, S. C. Read, S. Renwick, K. Rahn, R. P. Johnson, D. Alves, M. A. Karmali, H. Lior, S. A. McEwen, J. Spika, and C. L. Gyles. 1994. Verocytotoxin-producing Escherichia coli (VTEC) in the food chain: preharvest and processing perspectives, p. 17-24. In M. A. Karmali and A. G. Goglio (ed.). Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
73. Coad, N. A. G., T. Marshall, B. Rowe, and C. M. Taylor. 1991. Changes in the postenteropathic form of hemolytic uremic syndrome in children. Clin. Nephrol. 35:10-16.
74. Cockerill, F., III, G. Beebakhee, R. Soni, and P. Sherman. 1996. Polysac-charide side chains are not required for attaching and effacing adhesion of Escherichia coli O157:H7. Infect. Immun. 64:3196-3200.
75. Cordovez, A., V. Prado, L. Maggi, J. Cordero, J. Martinez, A. Misraji, R. Rios, G. Soza, A. Ojeda, and M. M. Levine. 1992. Enterohemorrhagic Escherichia coli associated with hemoiytic-uremic syndrome in Chilean children. J. Clin. Microbiol. 30:2153-2157.
76. Cray, W. C., and H. W. Moon. 1995. Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl. Environ. Microbiol. 61: 1586-1590.
77. Dean-Nystrom, E. A., B. T. Bosworth, W. C. Cray, Jr., and H. W. Moon. 1997. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect. Immun. 65:1842-1848.
78. DeGrandis, S., J. Ginsberg, M. Toone, S. Climie, J. Friesen, and J. Brunton. 1987. Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J. Bacteriol. 169:4313-4319.
79. DeGrandis, S., H. Law, J. Brunton, C. Gyles, and C. A. Lingwood. 1989. Globotetraosyl ceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 264:12520-12525.
80. Djafari, S., F. Ebel, C. Deibel, S. Kramer, M. Hudel, and T. Chakraborty. 1997. Characterization of an exported protease from Shiga toxin-producing Escherichia coli. Mol. Microbiol. 25:771-784.
81. Donnenberg, M. S., J. B. Kaper, and B. B. Finlay. 1997. Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol. 5:109-114.
82. Donnenberg, M. S., S. Tzipori, M. L. McKee, A. D. O'Brien, J. Alroy, and J. B. Kaper. 1993. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J. Clin. Invest. 92:1418-1424.
83. Donohue-Rolfe, A., D. W. Acheson, and G. T. Keusch. 1991. Shiga toxin: purification, structure, and function. Rev. Infect. Dis. 13(Suppl 4):S293-S297.
84. Donohue-Rolfe, A., M. A. Kolley, M. Bennish, and G. T. Keusch. 1986. Enzyme-linked immunosorbent assay for shigella toxin. J. Clin. Microbiol. 24:65-68.
85. Donohue-Rolfe, A., G. T. Keusch, C. Edson, D. Thorley-Lawsoh, and M. Jacewicz. 1984. Pathogenesis of Shigella diarrhoea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. J. Exp. Med. 160:1767-1781.
86. Dorn, C. R., and E. J. Angrick. 1991. Serotype O157:H7 Escherichia coli from bovine and meat sources. J. Clin. Microbiol. 29:1225-1231.
87. Downes, F. P., J. H. Green, K. Greene, N. Strockbine, J. G. Wells, and I. K. Wachsmuth. 1989. Development and evaluation of enzyme-linked immunosorbent assays for detection of Shiga-like toxin I and Shiga-like toxin II. J. Clin. Microbiol. 27:1292-1297.
88. Dytoc, M., R. Soni, F. Cockerill III, J. De-Azavedo, M. Louie, J. Brunton, and P. Sherman. 1993. Multiple determinants of verotoxin-producing Escherichia coli O157:H7 attachment-effacement. Infect. Immun. 61:3382-3391.
89. Dytoc, M. T., A. Ismaili, D. J. Philpott, R. Soni, J. L. Brunton, and P. M. Sherman. 1994. Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21. Infect. Immun. 62:3494-3505.
90. Ebel, F., C. Deibel, A. U. Kresse, C. A. Guzman, and T. Chakraborty. 1996. Temperature-and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli. Infect. Immun. 64:4472-4479.
91. Edelman, R., M. A. Karmali, and P. A. Fleming. 1988. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. J. Infect. Dis. 157:1102-1104.
92. Edwards, A., K. Arbuthnott, J. R. Stinson, H. C. Wong, C. Schmitt, and A. D. O'Brien. 1997. Humanization of monoclonalantibodies against Escherichia coli toxins Stx1 and Stx2, abstr. V110/VII, p. 113. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
93. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:335-337.
94. 93a.Finlay, B. B. Personal communication.
95. Fitzpatrick, M., V. Shah, R. S. Trompeter, M. J. Dillon, and T. M. Barratt. 1992. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int. 42:951-956.
96. Forsyth, K. D., A. C. Simpson, M. M. Fitzpatrick, T. M. Barratt, and R. J. Levinsky. 1989. Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome. Lancet ii:411.
97. Francis, D. H., J. E. Collins, and J. R. Duimstra. 1986. Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis. Infect. Immun. 51:953-956.
98. 96a.Frankel, G., D. C. A. Candy, E. Fabiani, J. Adu-Bobie, S. Gil, M. Novakova, A. D. Phillips, and G. Dougan. 1995. Molecular characterization of a carboxy-terminal cell-binding domain of intimin from enteropathogenic Escherichia coli. Infect. Immun. 63:4323-4328.
99. Fraser, M. E., M. M. Chernaia, Y. V. Kozlov, and M. N. James. 1994. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat. Struct. Biol. 1:59-64.
100. Fratamico, P. M., S. Bhaduri, and R. L. Buchanan. 1993. Studies on Escherichia coli serotype O157:H7 strains containing a 60-MDa plasmid and on 60-MDa plasmid-cured derivatives. J. Med. Microbiol. 39:371-381.
101. Fratamico, P. M., S. K. Sackitey, M. Wiedmann, and M. Y. Deng. 1995. Detection of Escherichia coli O157:H7 by multiplex PCR. J. Clin. Microbiol. 33:2188-2191.
102. Fujii, J., Y. Kinoshita, T. Kita, A. Higure, T. Takeda, N. Tanaka, and S. Yoshida. 1996. Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect. Immun. 64: 5053-5060.
103. - in mitomycin-treated mice. Infect. Immun. 62:3447-3453.
104. Fukushima, H., T. Hashizume, and T. Kitani. 1997. The massive outbreak of enterohemorrhagic E. coli O157 infections by food poisoning among the elementary school children in Sakai, Japan, in 1996, abstr. V6/VII, p. 111. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
105. Cannon, V. P. J., S. D'Souza, T. Graham, R. K. King, K. Rahn, and S. Read. 1997. Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity and identification of enterohemorrhagic Escherichia coli strains. J. Clin. Microbiol. 35:656-662.
106. Gannon, V. P. J., R. K. King, J. Y. Kim, and E. J. Thomas. 1992. Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef by using the polymerase chain reaction. Appl. Environ. Microbiol. 58:3809-3815.
107. Gannon, V. P. J., M. Rashed, R. K. King, and E. J. G. Thomas. 1993. Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli by using polymerase chain reaction. J. Clin. Microbiol. 31:1258-1274.
108. Gannon, V. P. J., C. Teerling, S. A. Masri, and C. L. Gyles. 1990. Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. J. Gen. Microbiol. 136:1125-1135.
109. Garred, O., B. van-Deurs, and K. Sandvig. 1995. Furin-induced cleavage and activation of Shiga toxin. J. Biol. Chem. 270:10817-10821.
110. Glynn, K., S. Cody, L. Cairns, R. Alexander, M. Fyfe, M. Samadpour, J. Lewis, B. Swaminathan, S. Abbott, R. Hoffman, J. Kobayashi, D. Vugia, and P. Griffin. 1997. International outbreak of Escherichia coli O157:H7 infections associated with unpasteurized commercial apple juice, abstr. V147/I, p. 18. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
111. Goldwater, P. N., and K. A. Bettelheim. 1994. The role of enterohaemorrhagic E. coli serotypes other than O157:H7 as causes of disease, p. 57-60. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
112. Goodson, M., and R. J. Rowbury. 1989. Habituation to normally lethal acidity by prior growth of Escherichia coli at a sub-lethal acid pH value. Lett. Appl. Microbiol. 8:77-79.
113. Gorden, J., and P. L. C. Small. 1993. Acid resistance in enteric bacteria. Infect. Immun. 61:364-367.
114. Gordon, V. M., S. C. Whipp, H. W. Moon, A. D. O'Brien, and J. E. Samuel. 1992. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect. Immun. 60:485-490.
115. Greatorex, J. S., and G. M. Thorne. 1994. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-urcmic syndrome patients and healthy subjects. J. Clin. Microbiol. 32:1172-1178.
116. Griffin, P. M., B. P. Bell, P. R. Cieslak, J. Tuttle, T. J. Barrett, M. P. Doyle, A. M. McNamara, A. M. Shefer, and J. G. Wells. 1994. Large outbreak of Escherichia coli O157:H7 infections in the Western United States: the big picture, p. 7-12. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
117. Griffin, P. M., and R. V. Tauxe. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, arid the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:60-98.
118. Gunzer, F., H. Bohm, H. Russmann, M. Bitzan, S. Aleksic, and H. Karch. 1992. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 30:1807-1810.
119. Gyles, C. L. 1992. Escherichia coli cytotoxins and enterotoxins. Can. J. Microbiol. 38:734-746.
120. Gyles, C. L., S. A. De Grandis, C. MacKenzie, and J. L. Brunton. 1988. Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli. Microb. Pathog. 5:419-426.
121. Habib, N. F., and M. P. Jackson. 1993. Roles of a ribosome-binding site and mRNA secondary structure in differential expression of Shiga toxin genes. J. Bacteriol. 175:597-603.
122. Habib, R., M. Levy, M. F. Gagnadoux, and M. Broyer. 1982. Prognosis of the hemolytic uremic syndrome in children. Adv. Nephrol. 11:99-128.
123. Haddad, J. E., and M. P. Jackson. 1993. Identification of the Shiga toxin A-subunit residues required for holotoxin assembly. J. Bacteriol. 175:7652-7657.
124. Hammermueller, J., and C. L. Gyles. 1994. The development of a rapid bioluminescent Vero cell assay, p. 113-116. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
125. Hammermueller, J., S. Kruth, J. Prescott, and C. Gyles. 1995. Detection of toxin genes in Escherichia coli isolated from normal dogs and dogs with diarrhea. Can. J. Vet. Res. 59:265-270.
126. Haque, Q. M., A. Sugiyama, Y. Iwade, Y. Midorikawa, and T. Yamauchi. 1996. Diarrheal and environmental isolates of Aeromonas spp. produce a toxin similar to Shiga-like toxin 1. Curr. Microbiol. 32:239-245.
127. Harel, Y., M. Silva, B. Giroir, A. Weinberg, T. B. Cleary, and B. Beutler. 1993. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by Shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J. Clin. Invest. 92:2110-2116.
128. Head, S. C., M. Petric, S. Richardson, M. Roscoe, and M. A. Karmali. 1988. Purification and characterization of verotoxin 2. FEMS Microbiol. Lett. 51:211-216.
129. Hockin, J. C., and H. Lior. 1987. Haemorrhagic colitis and hemolytic uremic syndrome caused by Escherichia coli O157:H7 in Canada. Can. Dis. Weekly Rep. 13:203-204.
130. Hovde, C. J., S. B. Calderwood, J. J. Mekalanos, and R. J. Collier. 1988. Evidence that glutamic acid 167 is an active site residue of Shiga-like toxin I. Proc. Natl. Acad. Sci. USA 85:2568-2572.
131. Hull, A. E., D. W. Acheson, P. Echeverria, A. Donohue-Rolfe, and G. T. Keusch. 1993. Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes. J. Clin. Microbiol. 31:1167-1172.
132. Hutchison, J., D. Stanimirovic, A. Shapiro, and G. Armstrong. 1997. Verotoxin causes cytotoxicity in human cerebral endothelial cells, abstr. V190/V, p. 91. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
133. Igarashi, K., T. Ogasawara, K. Ito, T. Yutsudo, and Y. Takeda. 1987. Inhibition of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes by Shiga-like I (VT1) from Escherichia coli O157:H7 and by Shiga toxin. FEMS. Microbiol. Lett. 44:91-94.
134. Imberechts, H., H. U. Bertschinger, M. Stamm, T. Sydler, P. Pohl, H. de Greve, J. P. Hernalsteens, M. van Montagu, and P. Lintermans. 1994. Prevalence of F107 fimbriae on Escherichia coli isolated from pigs with oedema disease or postweaning diarrhoea. Vet. Microbiol. 40:219-230.
135. Imberechts, H., H. de Greve, and P. Lintermans. 1992. The pathogenesis of edema disease in pigs. A review. Vet. Microbiol. 31:221-233.
136. Imberechts, H., H. de Greve, C. Schlicker, H, Bouchet, P. Pohl, G. Charlier, H. Bertschinger, P. Wild, J. Vandekerckhove, J. van Damme, M. van Montagu, and P. Lintermans. 1992. Characterization of F107 fimbriae of Escherichia coli 107/86, which causes edema disease in pigs, and nucleotide sequence of the F107 major fimbrial subunit gene, fedA. Infect. Immun. 60:1963-1971.
137. Ingram, D. T., C. G. Rigakos, D. Rollins, E. T. Mallinson, L. Carr, C. Lamichhane, and S. W. Joseph. 1997. Development and evaluation of a 24 hr method (E. coli SELeCT™) for the detection, isolation and quantification of Escherichia coli O157:H7 in raw ground meat, abstr. V192/II. p. 39. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
138. Inward, C. D., M. Varagunam, D. Adu, D. V. Milford, and C. M. Taylor. 1997. Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection. Arch. Dis. Child. 77:145-147.
139. Ismaili, A., D. J. Philpott, M. T. Dytoc, and P. M. Sherman. 1995. Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli. Infect. Immun. 63:3316-3326.
140. Ito, H., A. Terai, H. Kurazono, Y. Takeda, and M. Nishibuchi. 1990. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb. Pathog. 8:47-60.
141. Jackson, M. P. 1990. Structure-function analyses of Shiga toxin and the Shiga-like toxins. Microb. Pathog. 8:235-242.
142. Jackson, M. P. 1991. Detection of Shiga toxin-producing Shigella
143. Jackson, M. P. 1992. Identification of Shiga-like toxin type II producing Escherichia coli using the polymerase chain reaction and a digoxigenin labelled DNA probe. Mol. Cell. Probes 6:209-214.
144. Jackson, M. P., R. J. Neill, A. D. O'Brien, R. K. Holmes, and J. W. Newland. 1987. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44:109-114.
145. Jackson, M. P., J. W. Newland, R. K. Holmes, and A. D. O'Brien. 1987. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb. Pathog. 2:147-153.
146. Jams, K. G., and J. B. Kaper. 1996. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect. Immun. 64:4826-4829.
147. Jemal, C., J. E. Haddad, D. Begum, and M. P. Jackson. 1995. Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis. J. Bacteriol. 177:3128-3132.
148. Johnson, R., L. MacDonald, and S. Gray. 1997. Improved detection and isolation of verotoxigenic Escherichia coli in mixed cultures, abstr. V211/ VI. p. 108. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
149. Johnson, W. M., D. R. Pollard, H. Lior, S. D. Tyler, and K. R. Rozee. 1990. Differentiation of genes coding for Escherichia coli verotoxin 2 and verotoxin associated with porcine edema disease (VTe) by the polymerase chain reaction. J. Clin. Microbiol. 28:2351-2353.
150. Junkins, A. D., and M. P. Doyle. 1989. Comparison of adherence properties of Escherichia coli O157:H7 and a 60-megadalton plasmid-cured derivative. Curr. Microbiol. 19:21-27.
151. Kaplan, B. S. 1994. Clinical and pathophysiological aspects of the hemolytic uremic syndrome, p. 301-304. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
152. Karen, H., J. Heesemann, R. Laufs, A. D. O'Brien, C. O. Tacket, and M. M. Levine. 1987. A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect. Immun. 55:455-461.
153. Karch, H., C. Janetzki-Mittmann, S. Aleksic, and M. Datz. 1996. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. J. Clin. Microbiol. 34:516-519.
154. Karch, H., and T. Meyer. 1989. Evaluation of oligonucleotide probes for identification of Shiga-like-toxin-producing Escherichia coli. 3. Clin. Microbiol. 27:1180-1186.
155. Karch, H., and T. Meyer. 1989. Single primer pair for amplifying segments of distinct Shiga-like toxin genes by polymerase chain reaction. J. Clin. Microbiol. 27:2751-2757.
156. Karch, H., T. Meyer, H. Russmann, and J. Heesemann. 1992. Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect. Immun. 60:3464-3467.
157. Karch, H., H. Russmann, H. Schmidt, A. Schwarzkopf, and J. Heesemann. 1995. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J. Clin, Microbiol. 33:1602-1605.
158. Karmali, M. A. 1989. Infection by verotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
159. Karmali, M. A., M. Petric, C. Lim, R. Cheung, and G. S. Arbus. 1985. Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J. Clin. Microbiol. 22:614-619.
160. Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between hemolytic uremic syndrome and infection by Verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.
161. Karmali, M. A., M. Petric, M. Winkler, M. Bielaszewska, J. Brunton, N. van de Kar, T. Morooka, G. B. Nair, S. E. Richardson, and G. S. Arbus. 1994. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J. Clin. Microbiol. 32:1457-1463.
162. Karmali, M. A., B. T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli. Lancet i:619-620.
163. Karpman, D., A. Andrcasson, H. Thysell, B. S. Kaplan, and C. Svanborg. 1994. Serum and urinary cytokines in childhood haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura, p. 369-372. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
164. Karpman, D., H. Connell, M. Svensson, F. Scheutz, P. Alm, and C. Svanborg. 1997. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J. Infect. Dis. 175:611-620.
165. Kaye, S. A., C. B. Louise, B. Boyd, C. A. Lingwood, and T. G. Obrig. 1993. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect. Immun. 61:3886-3891.
166. Keane, W. F., R. Welch, G. Gekker, and P. K. Peterson. 1987. Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am. J. Pathol. 126:350-357.
167. Keene, W. E., J. M. McAnulty, F. C. Hoesly, L. P. Williams Jr., K. Hedberg, G. L. Oxman, T. J. Barrett, M. A. Pfaller, and D. W. Fleming. 1994. A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei. N. Engl. J. Med. 331:579-584.
168. Keene, W. E., E. Sazie, J. Kok, D. H. Rice, D. D. Hancock, V. K. Balan, T. Zhao, and M. P. Doyle. 1997. An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat. JAMA 277:1229-1231.
169. Kehl, K. S., P. Havens, C. E. Behnke, and D. W. Acheson. 1997. Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 35:2051-2054.
170. Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520.
171. Keusch, G. T., D. W. Acheson, L. Aaldering, J. Erban, and M. S. Jacewicz. 1996. Comparison of the effects of Shiga-like toxin 1 on cytokine-and butyrate-treated human umbilical and saphenous vein endothelial cells. J. Infect. Dis. 173:1164-1170.
172. Kiarash, A., B. Boyd, and C. A. Lingwood. 1994. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 269:11138-11146.
173. Kleanthous, H., H. R. Smith, S. M. Scotland, R. J. Gross, B. Rowe, C. M. Taylor, and D. V. Milford. 1990. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with Verocytotoxin producing Escherichia coli. 2. Microbiological aspects. Arch. Dis. Child. 65:722-727.
174. Knutton, S., T. Baldwin, P. H. Williams, and A. S. McNeisch. 1989. Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 57:1290-1298.
175. Kohan, D., P. Stricklett. D. Schmid, and A. Hughes. 1997. Possible cytokine-mediated autocrine and paracrine regulation of SLT-I cytotoxicity in human glomerular and tubular cells, abstr. V56/V, p. 81. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
176. Kongmuang, U., T. Honda, and T. Miwatani. 1987. Enzyme-linked immunosorbent assay to detect Shiga toxin of Shigella dysenteriae and related toxins. J. Clin. Microbiol. 25:115-118.
177. Konowalchuk, J., J. I. Speirs, and S. Stavric. 1977. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18:775-779.
178. Koster, F., V. Boonpucknavig, S. Sujaho, K. Oilman, and M. Rahaman. 1984. Renal histopathology in the hemolytic-uremic syndrome following shigellosis. Clin. Nephrol. 21:126-133.
179. Kozlov, Y. V., A. A. Kabishev, E. V. Lukyanov, and A. A. Bayev. 1988. The primary structure of the operons coding for Shigella dysenteriae toxin and temperate phage H30 Shiga-like toxin. Gene 67:213-221.
180. Krishnan, C., V. A. Fitzgerald, S. J. Dakin, and R. J. Behme. 1987. Laboratory investigation of outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7. J. Clin. Microbiol. 25:1043-1047.
181. Kudoh, Y., A. Kai, H. Obata, J. Kusinoki, C. Monma, M. Shingaki, Y. Yanagawa, S. Yamada, S. Matsushita, T. Ito, and K. Ohta. 1994. Epidemiological surveys on verocytotoxin-producing Escherichia coli infections in Japan, p. 53-56. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
182. Kudva, I. T., P. G. Hatfield, and C. J. Hovde. 1996. Escherichia coli O157:H7 in microbial flora of sheep. J. Clin. Microbiol. 34:431-433.
183. Lai, L.-C., L. A. Wainwright, K. D. Stone, and M. S. Donnenberg. 1997. A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells. Infect. Immun. 65:2211-2217.
184. Law, D., L. A. Ganguli, A. Donohue-Rolfe, and D. W. Acheson. 1992. Detection by ELISA of low numbers of Shiga-like toxin-producing Escherichia coli in mixed cultures after growth in the presence of mitomycin C. J. Med. Microbiol. 36:198-202.
185. Law, D., A. A. Hamour, D. W. Acheson, H. Panigrahi, L. A. Ganguli, and D. W. Denning. 1994. Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples. J. Med. Microbiol. 40:241-245.
186. Law, D., and J. Kelly. 1995. Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E. coli serogroups. Infect. Immun. 63:700-702.
187. Lesene, J. B., N. Rothschild, B. Erickson, S. Korec, R. Sisk, J. Keller, M. Arbus, P. V. Woolley, L. Chiazze, P. S. Schein, and J. R. Neefe. 1989. Cancer-associated hemolytic uremic syndrome: an analysis of 85 cases from a national registry. J. Clin. Oncol. 7:781-789.
188. Levine, M. M., J. Xu, J. B. Kaper, H. Lior, V. Prado, B. Tall, J. Nataro, H. Karen, and I. K. Wachsmuth. 1987. A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J. Infect. Dis. 156:175-182.
189. Leyer, G. J., L. Wang, and E. A. Johnson. 1995. Acid adaptation of Escherichia coli O157:H7 increases survival in acidic foods. Appl. Environ. Microbiol. 61:3752-3755.
190. Lin, Z., H. Kurazono, S. Yamasaki, and Y. Takeda. 1993. Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction. Microbiol. Immunol. 37:543-548.
191. Lin, Z., S. Yamasaki, H. Kurazono, M. Ohmura, T. Karasawa, T. Inoue, S. Sakamoto, T. Suganami, T. Takeoka, Y. Taniguchi, et al. 1993. Cloning and sequencing of two new Verotoxin 2 variant genes of Escherichia coli isolated from cases of human and bovine diarrhea. Microbiol. Immunol. 37:451-459.
192. Lindgren, S. W., A. R. Melton, and A. D. O'Brien. 1993. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61:3832-3842.
193. Lindgren, S. W., J. E. Samuel, C. K. Schmitt, and A. D. O'Brien. 1994. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemonhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62:623-631.
194. Lingwood, C. A. 1994. Verotoxin-binding in human renal sections. Nephron 66:21-28.
195. Lingwood, C. A. 1996. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4:147-153.
196. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. DeGrandis, and M. Karmali, M. 1987. Glycolipid binding of natural and cloned Escherichia coli produced verotoxin in vitro. 3. Biol. Chem. 262: 8834-8839.
197. Louie, M., J. De-Azavedo, R. Clarke, A. Borczyk, H. Lior, M. Richter, and J. Brunton. 1994. Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol. Infect. 112:449-461.
198. Louie, M., J. C. S. De-Azavedo, M. Y. C. Handelsman, C. G. Clark, B. Ally, M. Dytoc, P. Sherman, and J. Brunton. 1993. Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7. Jnfect. Immun. 61:4085-4092.
199. Louise, C. B., S. A. Kaye, B. Boyd, C. A. Lingwood, and T. G. Obrig. 1995. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. Infect. Immun. 63:2766-2769.
200. Louise, C. B., and T. G. Obrig. 1991. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:4173-4179.
201. Louise, C. B., and T. G. Obrig. 1992. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60:1536-1543.
202. Louise, C. B., and T. G. Obrig. 1995. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J. Infect. Dis. 172:1397-1401.
203. Louise, C. B., M. C. Tran, and T. G. Obrig. 1997. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-KB. Infect. Immun. 65:3337-3344.
204. Mackenzie, A. M. R., P. Lebel, E. Orrbine, L. Hyde, P. C. Rowe, F. Chan, and P. N. McLaine. 1997. Sensitivity and specificity of Meridian immunoassay tests for E. coli, abstr. V118/VI, p. 100. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
205. MacLeod, D. L., and C. L. Gyles. 1991. Immunization of pigs with a purified Shiga-like toxin II variant toxoid. Vet. Microbiol. 29:309-318.
206. Maneval, D. R., J. P. Nataro, and M. M. Levine. 1997. Identification of a novel fimbrial antigen in EHEC, abstr. V230/III, p. 66. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
207. March, S. B., and S. Ratnam. 1986. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J. Clin. Microbiol. 23:869-872.
208. Martin, D. L., K. L. MacDonald, K. E. White, J. T. Soler, and M. T. Osterholm. 1990. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N. Engl. J. Med. 323:1161-1167.
209. Marques, L. R. M., J. S. M. Peiris, S. J. Cryz, and A. D. O'Brien. 1987. Escherichia coli strains isolated from pigs produce a variant of Shiga-like toxin H. FEMS Microbiol. Lett. 44:33-38.
210. McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA 92:1664-1668.
211. McKee, M. L., A. R. Melton-Celsa, R. A. Moxley, D. H. Francis, and A. D. O'Brien. 1995. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect. Immun. 63:3739-3744.
212. McKee, M. L., and A. D. O'Brien. 1995. Investigation of enterohemorrhagic Escherichia coli O157:H7 adherence characteristics and invasion potential reveals a new attachment pattern shared by intestinal E. coli. Infect. Immun. 63:2070-2074.
213. McKee, M. L., and A. D. O'Brien. 1996. Truncated enterohemorrhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells. Infect. Immun. 64:2225-2233.
214. Melton-Celsa, A. R., S. C. Darnell, and A. D. O'Brien. 1996. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect. Immun. 64:1569-1576.
215. Mermin, J. H., E. D. Hilborn, A. Voetsch, M. Swartz, M. A. Lambert-Fair, J. Farrar, D. Vugia, J. Hadler, and L. Slutsker. 1997. A multistate outbreak of Escherichia coli O157:H7 infections associated with eating mesclun mix lettuce, abstr. V74/I, p. 9. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
216. Meyer, T., H. Karch, J. Hacker, H. Bocklage, and J. Heesemann. 1992. Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279. Zentbl. Bakteriol. 276:176-188.
217. Milford, D. V., C. M. Taylor, B. Gutteridge, S. M. Hall, B. Rowe, and H. Kleanthous. 1990. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. 1. Clinical and epidemiological aspects. Arch. Dis. Child. 65:715-721.
218. Milley, D. G., and L. H. Sekla. 1993. An enzyme-linked immunosorbent assay-based isolation procedure for verotoxigenic Escherichia coli. Appl. Environ. Microbiol. 59:4223-4229. (Erratum, 60:1704, 1994.)
219. Mizuguchi, M., S. Tanaka, I. Fujii, H. Tanizawa, Y. Suzuki, T. Igarashi, T. Yamanaka, T. Takeda, and M. Miwa. 1996. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. Acta Neuropathol. 91:254-262.
220. Mobassaleh, M., A. Donohne-Rolfe, M. Jacewicz, R. J. Grand, and G. T. Keusch. 1988. Pathogenesis of Shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for Shigella toxin involved in the fluid secretory response of rabbit small intestine. J. Infect. Dis. 157:1023-1031.
221. 3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine. Am. J. Physiol. 267:G618-24.
222. Monnens, L. 1997. Pathophysiology of HUS. Presented at the 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
223. Morgan, D., C. P. Nevraian, D. N. Hutchinson, A. M. Walker, B. Rowe, and F. Majid. 1993. Verotoxin producing Escherichia coli O157 infections associated with the consumption of yoghurt. Epidemiol. Infect. 111:181-187.
224. Morigi, M., G. Micheletti, M. Figliuzzi, B. Imberti, M. A. Karmali, A. Remuzzi, G. Remuzzi, and C. Zoja. 1995. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 86:4553-4558.
225. Morris, J. A., and W. J. Sojka. 1985. Escherichia coli as a pathogen in animals, p. 47-77. In M. Sussman (ed.), The virulence of Escherichia coli. Society for General Microbiology and Academic Press, Ltd., London, United Kingdom.
226. Morrison, D. M., D. L. J. Tyrell, and L. D. Jewell. 1985. Colonic biopsy in Verotoxin-induced hemorrhagic colitis and thrombotic thrombocyopenic purpura (TTP). Am. J. Clin. Pathol. 86:108-112.
227. Mühldorfer, I., J. Hacker, G. T. Keusch, D. W. Acheson, H. Tschape, A. V. Kaue, A. Ritter, T. Olschlager, and A. Donohue-Rolfe. 1996. Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect. Immun. 64:495-502.
228. Newburg, D. S., P. Chaturvedi, E. L. Lopez, S. Devoto, A. Fayad, and T. G. Cleary. 1993. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns. J. Infect. Dis. 168:476-479.
229. Newland, J. W., and R. J. Neill. 1988. DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages. J. Clin. Microbiol. 26:1292-1297.
230. Nielsen, N. O., and R. E. Clugston. 1971. Comparison of E. coli endotoxin shock and acute experimental edema disease in young pigs. Ann. N.Y. Acad. Sci. 176:176-189.
231. Nishikawa, Y., S. M. Scotland, H. R. Smith, G. A. Willshaw, and B. Rowe. 1995. Catabolite repression of the adhesion of Vero cytotoxin-producing Escherichia coli of serogroups O157 and O111. Microb. Pathog. 18:223-229.
232. Nyholm, P. G., J. L. Brunton, and C. A. Lingwood. 1995. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosyl-ceramide (Gb3). Int. J. Biol. Macromol. 17:199-204.
233. Nyholm, P. G., G. Magnusson, Z. Zheng, R. Norel, B. Binnington-Boyd, and C. A Lingwood. 1996. Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new giycolipid receptor for all verotoxins. Chem. Biol. 3:263-275.
234. O'Brien, A. D., and R. K. Holmes. 1987. Shiga and Shiga-like toxins. Microbiol. Rev. 51:206-220.
235. O'Brien, A. D., and G. D. La Veck. 1983. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect. Immun. 40:675-683.
236. O'Brien, A. D., G. D. LaVeck, M. R. Thompson, and S. B. Formal. 1982. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J. Infect. Dis. 146:763-769.
237. O'Brien, A. D., T. A. Lively, M. E. Chen, S. W. Rothman, and S. B. Formal. 1983. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (Shiga) like cytotoxin. Lancet i:702.
238. O'Brien, A. D., J. W. Newland, S. F. Miller, R. K. Holmes, H. W. Smith, and S. B. Formal. 1984. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226: 694-696.
239. Obrig, T. G., P. J. Del Vecchio, J. E. Brown, T. P. Moran, B. M. Rowland, T. K. Judge, and S. W. Rothman. 1988. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect. Immun. 56:2373-2378.
240. Obrig, T. G., C. B. Louise, C. A. Lingwood, B. Boyd, L. Barley-Maloney, and T. O. Daniel. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268:15484-15488.
241. Oelschlaeger, T. A., T. J. Barrett, and D. J. Kopecko. 1994. Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains. Infect. Immun. 62:5142-5150.
242. Ogasawara, T., K. Ito, K. Igarashi, T. Yutsudo, N. Nakabayashi, and Y. Takeda. 1988. Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes. Microb. Pathog. 4:127-135.
243. Ojeda, A., V. Prado, J. Martinez, C. Arellano, A. Borczyk, W. Johnson, H. Lior, and M. M. Levine. 1995. Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources. J. Clin. Microbiol. 33:2199-2201.
244. Oku, Y., T. Yitsuda, T. Hirayama, A. D. O'Brien, and Y. Takeda. 1989. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb. Pathog. 6:113-122.
245. Orr, P. H., V. Dong, M. L. Schroeder, and M. R. Ogborn. 1995. P1 blood group antigen expression and epidemic hemolytic uremic syndrome. Pediatr. Nephrol. 9:612-613.
246. Ostroff, S. M., P. I. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-999.
247. Park, C. H., and D. L. Hixon. 1995. New enzyme immunoassay for direct detection of Shiga-like toxins in stool specimens, abstr. D76. In Abstracts of the 35th Interscience Congress on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
248. Park, C. H., D. L. Hixon, W. L. Morrison, and C. B. Cook. 1994. Rapid diagnosis of enterohemorrhagic Escherichia coli O157:H7 directly from fecal specimens using immunofluorescence stain. Am. J. Clin. Pathol. 101: 91-94.
249. Park, C. H., and A. Jafir. Evaluation of the LMD ELISA for detection of Shiga-like toxins of Escherichia coli. 1997, abstr. V38/VI, p. 95. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
250. Park, C. H., N. M. Vandel, and D. L. Hixon. 1996. Rapid immunoassay for detection of Escherichia coli O157 directly from stool specimens. J. Clin. Microbiol. 34:988-990.
251. Parreira, V. R., C. W. Arns, and T. Yano. 1994. An agar-overlay method for detection of toxins produced by Escherichia coli. FEMS Microbiol. Lett. 120:303-306.
252. Paton, A. W., L. Beutin, and J. C. Paton. 1995. Heterogeneity of the amino-acid sequences of Escherichia coli Shiga-like toxin type-I operons. Gene 153:71-74.
253. Paton, A. W., A. J. Bourne, P. A. Manning, and J. C. Paton. 1995. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons. Infect. Immun. 63:2450-2458.
254. Paton, A. W., P. A. Manning, and J. C. Paton. 1995. Increased oral virulence of Escherichia coli expressing a variant Shiga-like toxin type II operon is associated with both A subunit residues Met4 and Gly102. Microb. Pathog. 19:185-191.
255. Paton, A. W., and J. C. Paton. 1994. Characterization of IS1203, an insertion sequence in Escherichia coli O111:H-. Gene 150:67-70.
256. Paton, A. W., and J. C. Paton. 1996. Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic uremic syndrome. J. Clin. Microbiol. 34:463-465.
257. o157. J, Clin. Microbiol. 36:598-602.
258. Paton, A. W., J. C. Paton, P. N. Goldwater, M. W. Heuzenroeder, and P. A. Manning. 1993. Sequence of a variant Shiga-like toxin type-I operon of Escherichia coli O111:H-. Gene 129:87-92.
259. Paton, A. W., J. C. Paton, P. N. Goldwater, and P. A. Manning. 1993. Direct detection of Escherichia coli Shiga-like toxin genes in primary fecal cultures by polymerase chain reaction. J. Clin. Microbiol. 31:3063-3067.
260. Paton, A. W., J. C. Paton, M. W. Heuzenroeder, P. N. Goldwater, and P. A. Manning. 1992. Cloning and nucleotide sequence of a variant Shiga-like toxin II gene from Escherichia coli OX3:H21 isolated from a case of sudden infant death syndrome. Microb. Pathog. 13:225-236.
261. Paton, A. W., J. C. Paton, and P. A. Manning. 1993. Polymerase chain reaction amplification, cloning and sequencing of variant Escherichia coli Shiga-like toxin type II operons. Microb. Pathog. 15:77-82.
262. Paton, A. W., R. Ratcliff, R. M. Doyle, J. Seymour-Murray, D. Davos, J. A. Lanser, and J. C. Paton. 1996. Molecular microbiological investigation of an outbreak of hemolytic uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J. Clin. Microbiol. 34:1622-1627.
263. Paton, A. W., E. Voss, P. A. Manning, and J. C. Paton. 1997. Shiga toxin-producing Escherichia coli isolates from cases of human disease show enhanced adherence to intestinal epithelial (Henle 407) cells. Infect. Immun. 65:3799-3805.
264. Paton, J. C., and A. W. Paton. 1996. Survival rate of mice after transient colonization with Escherichia coli clones carrying variant Shiga-like toxin type II operons. Microb. Pathog. 20:377-383.
265. Paton, J. C., and A. W. Paton. 1997. Instability of a Shiga toxin type 2 gene in Enterobacter cloacae. J. Clin. Microbiol. 35:1917.
266. Pavia, A. T., C. R. Nichols, D. P. Green, R. V. Tauxe, S. Mottice, K. D. Greene, J. G. Wells, R. L. Siegler, E. D. Brewer, D. Hannon, and P. A. Blake. 1990. Hemolytic uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiological observations. J. Pediatr. 116:544-551.
267. Pellizzari, A., H. Pang, and C. A. Lingwood. 1992. Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry 31:1363-1370.
268. Perera, L. P., L. R. M. Marques, and A. D. O'Brien. 1988. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay. J. Clin. Microbiol. 26:2127-2131.
269. Pierard, D., D. Stevens, L. Moriau, H. Lior, and S. Lauwers. 1994. Three years PCR screening for VTEC in human stools in Brussels, p. 33-36. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
270. Pierard, D., L. Van Damme, D. Stevens, L. Moriau, and S. Lauwers. 1994. Detection of verocytotoxin-producing Escherichia coli in meat in Belgium, p. 77-80. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
271. Pirro, F., L. H. Wieler, K. Failing, R. Bauerfeind, and G. Baljer. 1995. Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle. Vet. Microbiol. 43:131-141.
272. Pollard, D. R., W. M. Johnson, H. Lior, S. D. Tyler, and K. R. Rozee. 1990. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J. Clin. Microbiol. 28:540-545.
273. Proulx, F., J. P. Turgeon, G. Delage, L. Lafleur, and L. Chicoine. 1992. Randomized controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J. Pediatr. 121:299-303.
274. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180.
275. Ramotar, K., E. Henderson, R. Szumski, and T. J. Louie. 1995. Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli. J. Clin. Microbiol. 33:1114-1120.
276. Ramotar, K., B. Waldhart, D. Church, R. Szumski, and T. J. Louie. 1995. Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR. J. Clin. Microbiol. 33:519-524.
277. Ratnam, S., S. B. March, R. Ahmed, G. S. Bezanson, and S. Kasatiya. 1988. Characterization of Escherichia coli serotype O157:H7. J. Clin. Microbiol. 26:2006-2012.
278. Read, S. C., R, C. Clarke, A. Martin, S. A. De Grandis, J. Hii, S. McEwen, and C. L. Gyles. 1992. Polymerase chain reaction for detection of verocytotoxigenic Escherichia coli isolated from animal and food sources. Mol. Cell. Probes 6:153-161.
279. Reida, P., M. Wolff, H. W. Pohls, W. Kuhlmann, A. Lehmacher, S. Aleksic, H. Karch, and J. Bockemuhl. 1994. An outbreak due to enterohaemorrhagic Escherichia coli O157:H7 in a children day care centre characterized by person-to-person transmission and environmental contamination. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 281:534-543.
280. Reymond, D., M. A. Karmali, I. Clarke, M. Winkler, and M. Petric. 1997. Comparison of the Western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1. J. Clin. Microbiol. 35:609-613.
281. Richardson, S. E., M. A. Karmali, L. E. Becker, and C. R. Smith. 1988. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum. Pathol. 19:1102-1108.
282. Richardson, S. E., T. A. Rotman, V. Jay, C. R. Smith, L. E. Becker, M. Petric, N. F. Olivieri, and M. A. Karmali. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60:4154-4167.
283. Riley, L. W. 1987. The epidemiologic, clinical, and microbiological features of hemorrhagic colitis. Annu. Rev. Microbiol. 41:383-407.
284. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
285. Ritchie, M., S. Partington, J. Jessop, and M. T. Kelly. 1992. Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection. J. Clin. Microbiol. 30:461-464.
286. Rivas, M., L. E. Voyer, M. I. Tous, M. F. de Mana, N. Leardini, R. Wainsztein, R. Callejo, B. Quadri, and V. Prado. 1994. Verotoxin-producing Escherichia coli infection in household contacts of children with the hemolytic uremic syndrome, p. 49-52. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B. V., Amsterdam, The Netherlands.
287. Robinson, L. A., R. M. Hurley, C. Lingwood, and D. G. Matsell. 1995. Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells. Pediatr. Nephrol. 9:700-704.
288. Rogers, J. E., G. Armstrong, and A. D. O'Brien. 1997. Therapeutic value of Stx-specific antibodies or Synsorb in Streptomycin (STR)-treated mice orally infected with Shiga toxin-producing Escherichia coli (STEC), abstr. V149/VII, p. 114. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
289. Russmann, H., H. Schmidt, J. Heesemann, A. Caprioli, and H. Karch. 1994. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J. Med. Microbiol. 40:338-343.
290. Saleh, M. T., J. Ferguson, J. M. Boggs, and J. Gariepy. 1996. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes. Biochemistry 35: 9325-9334.
291. Samuel, J. E., L. P. Perera, S. Ward, A. D. O'Brien, V. Ginsburg, and H. C. Krivan. 1990. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect. Immun. 58:611-618.
292. Sandbu, K. S., R. C. Clarke, K. McFadden, A. Brouwer, M. Louie, J. Wilson, H. Lior, and C. L. Gyles. 1996. Prevalence of the eaeA gene in verotoxigenic Escherichia coli strains from dairy cattle in Southwest Ontario. Epidemiol. Infect. 116:1-7.
293. Sandvig, K., O. Garred, K. Prydz, J. V. Kozlov, S. H. Hansen, and B. van Deurs. 1992. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510-512.
294. Sandvig, K., S. Olsnes, J. E. Brown, O. W. Petersen, and B. van Deurs. 1989 Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J. Cell Biol. 108:1331-1343.
295. Sandvig, K., M. Ryd, O. Garred, E. Schweda, P. K. Holm, and B. van Deurs. 1994. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and CAMP. J. Cell Biol. 126:53-64.
296. Sandvig, K., and B. van Deurs. 1996. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev. 76:949-966.
297. Sauders, B. D., and J. A. Kiehlbauch. 1997. Adaptation of a procedure used to isolate Escherichia coli O157:H7 from ground beef for use with implicated liquid vehicles, abstr. P-104. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
298. Savarino, S. J., A. Fasano, D. C. Robertson, and M. M. Levine. 1991. Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J. Clin. Invest. 87:1450-1455.
299. Savarino, S. J., A. McVeigh, J. Watson, A. Cravioto, J. Molina, P. Echeverria, M. K. Bhan, M. M. Levine, and A. Fasano. 1996. Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli. J. Infect. Dis. 173:1019-1022.
300. Saxena, S. A., A. D. O'Brien, and E. J. Ackerman. 1989. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28S RNA when microinjected into Xenopus oocytes. J. Biol. Chem. 264:596-601.
301. Scheffer, J., W. König, J. Hacker, and W. Goebel. 1985. Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect. Immun. 50:271-278.
302. Schmidt, H., L. Beutin, and H. Karch. 1995. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63:1055-1061.
303. Schmidt, H., and H. Karch. 1996. Enterohemolytic phenotypes and genotypes of Shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome. J. Clin. Microbiol. 34:2364-2367.
304. Schmidt, H., H. Karch, and L. Beutin. 1994. The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. FEMS Microbiol. Lett. 117:189-196.
305. Schmidt, H., C. Kernbach, and H. Karch. 1996. Analysis of the EHEC hly operon and its location in the physical map of the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 142:907-914.
306. Schmidt, H., M. Montag, J. Bockemuhl, J. Heesemann, and H. Karch. 1993. Shiga-like toxin H-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect. Immun. 61:534-543.
307. - strain E32511. Infect. Immun. 59:1065-1073.
308. Schoonderwoerd, M., R. C. Clarke, A. A. van Dreumel, and S. A. Rawluk. 1988. Colitis in calves: natural and experimental infection with a verotoxin-producing strain of Escherichia coli O111:NM. Can. J. Vet. Res. 52:484-487.
309. Scotland, S. M., B. Rowe, H. R. Smith, G. A. Willshaw, and R. J. Gross. 1988. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J. Med. Microbiol. 25:237-243.
310. Scotland, S. M., H. R. Smith, and B. Rowe. 1985. Two distinct toxins active on vero cells from Escherichia coli 0157. Lancet ii:885-886.
311. Scotland, S. M., H. R. Smith, G. A. Willshaw, and B. Rowe. 1983. Verocytotoxin production in strains of Escherichia coli is determined by genes carried on bacteriophage. Lancet ii:216.
312. Sherman, P., F. Cockerill III, R. Soni, and J. Brunton. 1991. Outer membranes are competitive inhibitors of Escherichia coli O157:H7 adherence to epithelial cells. Infect. Immun. 59:890-899.
313. Sherman, P., and R. Soni. 1988. Adherence of Vero cytotoxin-producing Escherichia coli of serotype O157:H7 to human epithelial cells in tissue culture: role of outer membranes as bacterial adhesins. J. Med. Microbiol. 26:11-17.
314. Sherman, P., R. Soni, and M. Karmali. 1988. Attaching and effacing adherence of vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo. Infect. Immun. 56:756-761.
315. Sherman, P., R. Soni, M. Petric, and M. Karmali. 1987. Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7. Infect. Immun. 55:1824-1829.
316. Shibolet, O., A. Shina, S. Rosen, T. G. Cleary, M. Brezis, and S. Ashkenazi. 1997. Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys. FEMS Immunol. Med. Microbiol. 18:55-60.
317. Skinner, L. M., and M. P. Jackson. 1997. Investigation of ribosome binding by the Shiga toxin A1 subunit, using competition and site-directed mutagenesis. J. Bacteriol. 179:1368-1374.
318. Smith, H. R., N. P. Day, S. M. Scotland, R. J. Gross, and B. Rowe. 1984. Phage-determined production of vero cytotoxin in strains of Escherichia coli serogroup O157. Lancet i:1242-1243.
319. Smith, H. R., and S. M. Scotland. 1988. Vero cytotoxin-producing strains of Escherichia coli. J. Med. Microbiol. 26:77-85.
320. Smith, H. R., and S. M. Scotland. 1993. Isolation and identification methods for Escherichia coli O157 and other Vero cytotoxin producing strains. J. Clin. Pathol. 46:10-17.
321. Sohel, I., J. L. Puente, S. W. Ramer, D. Bieber, C.-Y. Wu, and G. K. Schoolnik. 1996. Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis. J. Bacteriol. 178: 2613-2628.
322. Sowers, E. G., J. G. Wells, and N. A. Strockbine. 1996. Evaluation of commercial latex reagents for identification of O157 and H7 antigens of Escherichia coli. J. Clin. Microbiol. 34:1286-1289.
323. Speirs, J. I., and M. Akhtar. 1991. Detection of Escherichia coli cytotoxins by enzyme-linked immunosorbent assays. Can. J. Microbiol. 37:650-653.
324. Stein, P. E., A. Boodhoo, G. J. Tyrrell, J. L. Brunton, and R. J. Read. 1992. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 355:748-750.
325. Stewart, A. I., G. A. Jones, J. McMenamin, A. K. R. Chaudhuri, and W. T. A. Todd. 1997. Central Scotland Escherichia coli O157 outbreak -clinical aspects, abstr. V212/Vii, p. 115. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemoiytic Uremic Syndrome Inc., Melville, N.Y.
326. Stone, K. D., H.-Z. Zhang, L. K. Carlson, and M. S. Donnenberg. 1996. A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for the biogenesis of a type IV pilus. Mol. Microbiol. 20:325-337.
327. Strockbine, N. A., M. P. Jackson, L. M. Sung, R. K. Holmes, and A. D. O'Brien. 1988. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J. Bacteriol. 170:1116-1122.
328. Strockbine, N. A., L. R. M. Marques, R. K. Holmes, and A. D. O'Brien. 1985. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect. Immun. 50:695-700.
329. Strockbine, N. A., L. R. M. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
330. Su, G.-F., H. N. Brahmbhatt, J. Wehland, M. Rohde, and K. N. Timmis. 1992. Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses. Infect. Immun. 60:3345-3359.
331. Sung, L. M., M. P. Jackson, A. D. O'Brien, and R. K. Holmes. 1990. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli. J. Bacteriol. 172:6386-6395.
332. Suttorp, N., B. Flöer, H. Schnittler, W. Seeger, and S. Bhakdi. 1990. Effects of Escherichia coli hemolysin on endothelial cell function. Infect. Immun. 58:3796-3801.
333. Szu, S. C. 1997. LPS-based vaccines. Presented at the 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
334. Takeda, T., S. Dohi, T. Igarashi, T. Yamanaka, K. Yoshiya, and N. Kobayashi. 1993. Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome. J. Infect. 27:339-341.
335. Takeda, T., M. Tanimura, K. Yoshino, E. Matsuda, H. Uchida, and N. Ikeda. 1997. Early use of antibiotics for STEC O157:H7 infection reduces the risk of hemolytic uremic syndrome. Presented at the 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemotytic Uremic Syndrome Inc., Melville, N.Y.
336. Tarr, P. I. 1995. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin. Infect. Dis. 20:1-8.
337. Tarr, P. I., S. S. Bilge, J. A. Vary, N. M. Tang, M. R. Baylor, K. Potter, T. E. Besser, and S. L. Moseley. 1995. Adherence and colonization mechanisms of Escherichia coli O157:H7, p. 119-124. In Abstracts of the 31st US-Japan Cholera and Related Diarrheal Diseases Conference.
338. Tashiro, H., S. Miura, I. Kurose, D. Fukumura, H. Suzuki, M. Suematsu, M. Yoshioka, M. Tsuchiya, A. Kai, and Y. Kudoh. 1994. Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances. Dig. Dis. Sci. 39:1230-1238.
339. Taylor, C. M. 1994. A critical review of haemolytic uraemic syndrome pathophysiology, p. 305-308. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B. V., Amsterdam, The Netherlands.
340. Taylor, C. M., D. V. Milford, P. E. Rose, T. C. F. Roy, and B. Rowe. 1990. The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome. Pediatr. Nephrol. 4:59-61.
341. Tesh, V. L., J. A. Burns, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:3392-3402.
342. Tesh, V. L., and A. D. O'Brien. 1991. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol. Microbiol. 5:1817-1822.
343. Tesh, V. L., B. Ramegowda, and J. E. Samuel. 1994. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect. Immun. 62:5085-5094.
344. Tesh, V. L., J. E. Samuel, J. A. Burris, J. W. Owens, F. B. Taylor, Jr., and R. L. Siegler. 1994. Quantitation and localization of Shiga toxin/Shiga-like toxin-binding glycolipid receptors in human and baboon tissues, p. 189-192. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
345. Tesh, V. L., J. E. Samuel, L. P. Perera, J. B. Sharefkin, and A. D. O'Brien. 1991. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164:344-352.
346. Thomas, A., T. Cheasty, H. Chart, and B. Rowe. 1994. Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H-and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 13:1074-1076.
347. Thomas, A., H. R. Smith, G. A. Willshaw, and B. Rowe. 1991. Non-radio-actively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2, and VT2 variant. Mol. Cell. Probes 5:129-135.
348. Thompson, J. S., D. S. Hodge, and A. A. Borczyk. 1990. Rapid biochemical test to identify verocytotoxin-positive strains of Escherichia coli serotype O157. J. Clin. Microbiol. 28:2165-2168.
349. Toth, I., M. L. Cohen, H. S. Rumschlag, L. W. Riley, E. H. White, J. H. Carr, W. W. Bond, and I. K. Wachsmuth. 1990. Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect. Immun. 58:1223-1231.
350. Tschäpe, H., R. Prager, W. Streckel, A. Fruth, and G. Böhme. 1994. Outbreak of cases of hemolytic uremic syndromes and gastroenteritis in a nursery school - verotoxinogenic Citrobacter freundii as a causative agent, abstr. O1.8, p. 22. In VTEC'94: 2nd International Symposium and Workshop on Verocytotoxin (Shiga-Like Toxin)-Producing Escherichia coli infections. Italian Association of Clinical Microbiologists, Milan.
351. Tyler, S. D., W. M. Johnson, H. Lior, G. Wang, and K. R. Rozee. 1991. Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J. Clin. Microbiol. 29:1339-1343.
352. Tyrrell, G. J., K. Kainotar, B. Toye, B. Boyd, C. A. Lingwood, and J. L. Bruntnn. 1992. Alteration of the carbohydrate binding specificity of verotoxins from Galα1-4Gal to GalNAcβ1-3Galα1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc. Natl. Acad. Sci. USA 89:524-528.
353. Tzipori, S., R. Gibson, and J. Montanaro. 1989. Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic . Escherichia coli in piglets and the role of plasmid-mediated factors. Infect. Immun. 57:1142-1150.
354. Tzipori, S., F. Gunzer, M. S. Donnenberg, L. de Montigny, J. B. Kaper, and A. Donobue-Rolfe. 1995. The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect. Immun. 63:3621-3627.
355. Tzipori, S., H. Karen, I. K. Wachsmuth, R. M. Robins-Browne, A. D. O'Brien, H. Lior, M. L. Cohen, J. Smithers, and M. M. Levine. 1987. Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect. Immun. 55:3117-3125.
356. Vagts, D., H. P. Dienes, P. J. Barth, H. Ronneberger, K. D. Hungerer, and S. Bhakdi. 1993. In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys. Med. Microbiol. Immunol. 128:1-12.
357. van de Kar, N. C., T. Kooistra, M. Vermeer, W. Lessiauer, L. A. Monnens, and V. W. van Hinsbergh. 1995. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. Blood 85:734-743.
358. van de Kar, N. C., L. A. Monnens, M. A. Karmali, and V. W. van Hinsbergh. 1992. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764.
359. van de Kar, N. C., H. G. R. Roelofs, H. L. Muytjens, J. J. M. Tolboom, H. Chart, and L. A. H. Monnens. 1994. Verocytotoxin-producing Escherichia coli infection in patients with hemolytic syndrome and their family-members in the Netherlands, p. 45-48. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
360. van Setten, P. A., L. A. Monnens, R. G. Verstraten, L. P. van den Heuvel, and V. W. van Hinsbergh. 1996. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183.
361. van Setten, P., L. van den Heuvel, V. van Hinsbergh, F. Preijers, and L. Monnens. 1997. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) are elevated in HUS patients, abstr. V59/V, p. 83. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
362. Waddell, T., S. Head, M. Petric, A. Cohen, and C. A. Lingwood, C. A. 1988. Globotriosyl ceramide is specifically recognized by the Escherichia coli Vcrotoxin 2. Biochem. Biophys. Res. Commun. 152:674-679.
363. Wadolkowski, E. A., J. A. Burris, and A. D. O'Brien. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 58:2438-2445.
364. Wadolkowski, E. A., L. M. Sung, J. A. Burris, J. E. Samuel, and A. D. O'Brien. 1990. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect. Immun. 58:3959-3965.
365. Walters, M. D., U. Matthei, R. Jay, M. J. Dillon, and T. M. Barratt. 1989. The polymorphonuclear count in childhood hemolytic uremic syndrome. Pediatr. Nephrol. 3:130-134.
366. Walterspiel, J. N., S. Ashkenazi, A. L. Morrow, and T. G. Cleary. 1992. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection. 20:25-29.
367. Waterman, S. R., and P. L. Small. 1996. Characterization of the acid resistance phenotype and rpoS alleles of Shiga-like toxin-producing Escherichia coli. Infect. Immun. 64:2808-2811.
368. Weinstein, D. L., R. K. Holmes, and A. D. O'Brien. 1988. Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli. Infect. Immun. 56:106-111.
369. Weinstein, D. L., M. P. Jackson, L. P. Perera, R. K. Holmes, and A. D. O'Brien. 1989. The in vivo formation of hybrid toxins comprised of Shiga toxin and the Shiga-like toxins and the role of the B subunit in localization and cytotoxic activity. Infect. Immun. 57:3743-3750.
370. Weinstein, D. L., M. P. Jackson, J. E. Samuel, R. K. Holmes, and A. D. O'Brien. 1988. Cloning and sequencing of a Shiga-like toxin type II variant from an Escherichia coli strain responsible for edema disease of swine. J. Bacteriol. 170:4223-4230.
371. Welch, R. A. 1991. Pore-forming cytolysins of Gram-negative bacteria. Mol. Microbiol. 5:521-528.
372. Wells, J. G., B. R. Davis, I. K. Wachsmuth, L. W. Riley, R. S. Remis, R. Sokolow, and G. K. Morris. 1983. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia serotype. J. Clin. Microbiol. 18:512-520.
373. Wieler, L. H., E. Vieler, C. Erpenstein, T. Schlapp, H. Steinruck, R. Bauerfeind, A. Byomi, and G. Baljer. 1996. Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. J. Clin. Microbiol. 34:2980-2984.
374. Willshaw, G. A., S. M. Scotland, H. R. Smith, T. Cheasty, A. Thomas, and B. Rowe. 1994. Hybridization of strains of Escherichia coli O157 with probes derived from the eaeA gene of enteropathogenic E. coli and the eaeA homolog from a Vero cytotoxin-producing strain of E. coli O157. J. Clin. Microbiol. 32:897-902.
375. Willshaw, G. A., S. M. Scotland, H. R. Smith, and B. Rowe. 1992. Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J. Infect. Dis. 166:797-802.
376. Willshaw, G. A., H. R. Smith, S. M. Scotland, A. M. Field, and B. Rowe. 1987. Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J. Gen. Microbiol. 133:1309-1317.
377. Wilson, J. B., R. C. Clarke, S. A. Renwick, K. Rahn, R. P. Johnson, M. A. Karmali, H. Lior, D. Alves, C. L. Gyles, K. S. Sandhu, S. A. McEwen, and J. S. Spika. 1996. Vero cytotoxigenic Escherichia coli infection in dairy farm families. J. Infect. Dis. 174:1021-1027.
378. Wolf, L. E., D. W. Acheson, L. L. Lincicome, and G. T. Keusch. 1997. Subinhibitory concentrations of antibiotics increase the release of Shiga toxin from E. coli O157:H7 in vitro, abstr. V145/III, p. 60. In 3rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections. Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc., Melville, N.Y.
379. Wray, C., L. P. Randall, I. M. McLaren, and M. J. Woodward. 1994. Verocytotoxic Escherichia coli from animals, their incidence and detection, p. 69-72. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands.
380. Yamada, S., A. Kai, and Y. Kudoh. 1994. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 32:955-959.
381. Yamasaki, S., M. Furutani, K. Ito, K. Igarashi, M. Nishibuchi, and Y. Takeda. 1991. Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. Microb. Pathog. 11:1-9.
382. Yu, J., and J. B. Kaper. 1992. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 6:411-417.
383. Zadik, P. M., P. A. Chapman, and C. A. Siddons. 1993. Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. J. Med. Microbiol. 39:155-158.
384. Zhao, S., J. Meng, M. P. Doyle, R. Meinersman, G. Wang, and P. Zhao. 1996. A low molecular weight outer-membrane protein of Escherichia coli O157:H7 associated with adherence to INT407 cells and chicken caeca. J. Med. Microbiol. 45:90-96.
385. Zoja, C., D. Corna, C. Farina, G. Sacchi, C. Lingwood, M. P. Doyle, V. V. Padhye, M. Abbate, and G. Remuzzi. 1992. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J. Lab. Clin. Med. 120:229-238.